Received another investigational agent within  days of enrollment
Received an investigational agent within  days prior to enrollment
Received an investigational agent for any indication within  days prior to first treatment.
Received an investigational agent within  days prior to starting study treatment
Biologic therapy: patients should have received their last dose of biologic agent >=  days prior to enrollment; in the event the patient has received another biologic agent and has experienced >= grade  myelosuppression, then at least three () weeks must have elapsed prior to enrollment; if the investigational or biologic agent has a prolonged half-life then at least three () weeks interval is required
Received an investigational agent within  days prior to enrollment
Received an investigational agent within  days prior to enrollment
Received an investigational agent within  days prior to enrollment
Received an investigational agent within  days prior to enrollment
Patients who have received any other investigational agent =<  days prior to registration are not eligible
Received an investigational agent within  days prior to enrollment
Received an investigational agent within  days prior to enrollment
Received any investigational agent for any indication within  days prior to first treatment.
Patients who have received any investigational treatment agent within the last  days.
Received an investigational agent within  days prior to enrollment
Patients who have received another investigational agent within the previous  months
Received any investigational agent within the  days before the start of ALT-
Patient who has received investigation agent within  days prior to enrollment
Received an investigational agent within  days prior to enrollment
Patients who have received any investigational agent within  days prior to day 
Subjects who received any investigational agent ? days of study drug initiation.
Subjects who received an investigational agent < days prior to their first day of study drug administration.
The patient has received treatment with another investigational agent within  days of study entry.
Received an investigational agent within  weeks prior to enrollment
Previously received an investigational antineoplastic agent for NSCLC.
Patients who have received treatment with any other investigational agent within  weeks before enrollment.
Received an investigational agent within  days prior to registration
Patients must have received their last dose of any other investigational agent greater than  days prior to enrollment (with exception of fluorothymidine F- [FLT])\r\n* Patients must have received their last dose of any other biologic agent greater than  days prior to enrollment
Received an investigational agent within  weeks prior to enrollment
Patients who have received any investigational agent within  weeks of enrollment
Patients who have received any other investigational agent in a -day period prior to enrollment in this study
Received an investigational agent within  days prior to enrollment
Received anticancer agent(s) or an investigational agent within  days prior to CD, or radiotherapy within  days prior Cycle  Day 
Treatment with investigational agent within  days prior to enrollment
Received an investigational agent within  days prior to enrollment
Received an investigational agent for another disease within  days prior to enrollment
Subjects who have received any other investigational drug or agent within  days of first dose of TH-
Recently received an investigational agent or device
Received an investigational agent within  days prior to enrollment
The patient received treatment with another investigational agent within  days of screening.
Patient received chemotherapy, biological or investigational agent ?  days prior to enrollment.
Received investigational therapy or procedure ?  days prior to enrollment.
Received an investigational agent for any indication within  days prior to first treatment
Received an investigational agent within  days prior to enrollment
Received an investigational agent within  days prior to enrollment
Received an investigational agent within  days prior to enrollment
Received any investigational agent =<  days before Treg infusions
Received an investigational agent in another investigational drug or vaccine trial within  days prior to surgery
Received an investigational agent within  days prior to enrollment
Received an investigational agent in another investigational drug or vaccine trial within  days prior to surgery